Health Catalyst, Inc. is a healthcare data-and-analytics technology and services company headquartered in the Salt Lake City metropolitan area. It was incorporated in Delaware in September 2011 under the name HQC Holdings, Inc., and adopted its current name in March 2017, though the operating business traces to 2008 — a lineage the current CEO references directly, describing "eighteen years working with health systems" on the Q2 2026 earnings call (Q2 2026 earnings release, 6 Aug 2026). The company completed its initial public offering in July 2019.
**Positioning statement (150 words).** Health Catalyst occupies the healthcare-specific layer of the provider data stack: it ingests, normalises and governs clinical, claims, financial and operational data for health systems, then sells analytics applications and human expertise on top of it. Its distinctive asset is not infrastructure — management now openly concedes the data-platform layer has commoditised against Databricks, Snowflake and Microsoft — but a proprietary corpus of measured improvement outcomes accumulated over 18 years and more than 2,000 documented, client-verified improvements. The 2026 strategy under new CEO Ben Albert reframes the company as a "healthcare intelligence" business: an AI-enabled improvement layer that quantifies, prioritises and sequences cost, clinical-quality, ambulatory-growth and consumer interventions. Execution risk is acute. The company is simultaneously migrating clients off its legacy DOS platform, restructuring its cost base, having divested its most profitable software unit, and carrying an accumulated deficit above USD 1.5 billion against a market capitalisation near USD 135 million.
---
### 2.1 The company's own description
The FY2025 Form 10-K opens with an unchanged framing: *"We are a leading provider of data and analytics technology and services to healthcare organizations. Our Solution comprises our cloud-based data and analytics platform, software applications, and expertise. Our clients, which are primarily healthcare providers, use our Solution to manage their data, derive analytical insights to operate their organization, and produce measurable clinical, financial, and operational improvements. We envision a future where all healthcare decisions are data-informed."*
The company organises its self-description around three components: (i) the Ignite Data & Analytics Platform, a healthcare-specific, cloud-based, open and self-service ecosystem for analytics, application development and interoperability; (ii) Applications, software analytics products built on Ignite across five focus areas — Clinical Improvement, Revenue & Cost Improvement, Ambulatory Operations, Measures & Registries, and Data & Analytics; and (iii) Expertise, a services organisation of data engineers, data scientists, clinicians and healthcare administrators delivering implementation, analytics, abstraction, cost-accounting and Tech-Enabled Managed Services (TEMS).
The company describes its operating philosophy through the "Health Catalyst Flywheel": team-member engagement drives quality of work, which drives measurable client improvement, which drives client trust, renewal, expansion and referral, which drives predictable financial performance. This construct is not decorative — it is referenced in the executive compensation design disclosed in the 10-K/A, where annual bonus outcomes for all team members are tied to client outcomes, growth and Adjusted EBITDA.
By August 2026 the company's boilerplate had been rewritten materially. The Q2 2026 release describes Health Catalyst as *"a healthcare intelligence company designed to accelerate measurable improvement for health systems across cost, clinical, and consumer performance,"* backed by *"deep domain expertise, proprietary AI-driven technology, and $2.8 billion in documented outcomes."* The shift from "data and analytics technology and services" to "healthcare intelligence" is the clearest single marker of the strategy reset.
### 2.2 Independent characterisation
Health Catalyst is, in economic terms, a hybrid of three businesses that have historically been bundled and are now being deliberately unbundled.
The first is a healthcare data-platform business (formerly DOS, now Ignite) sold on multi-year subscription. This is the anchor relationship: it creates switching costs, it is the surface on which applications are sold, and it is the layer under most competitive pressure. Management's Q1 2026 admission that "healthcare data infrastructure has increasingly commoditized" is a significant concession from a company whose original thesis was that healthcare data warehousing required purpose-built architecture.
The second is a portfolio of point-solution applications, largely assembled through twelve acquisitions since 2018 — patient engagement (Twistle, Upfront), care orchestration (Lumeon), oncology (Carevive), registries (ARMUS, CRStar/ERS), measures (MeasureAble/Able Health), cost accounting (PowerCosting), labour management (PowerLabor), interoperability (Ninja Universe/KPI Ninja), cybersecurity (Intraprise), and — until 31 July 2026 — mid-revenue-cycle (Vitalware). These applications carry higher gross margins than services and are the intended vehicle for AI monetisation.
The third is a professional services and managed-services organisation. This is the structurally problematic segment: FY2025 adjusted gross margin of 18.3% and GAAP gross margin of 12.8%, on revenue that declined 8% year over year. Management now guides this business to roughly USD 55 million annually exiting 2026, versus USD 111.7 million in FY2024 — a deliberate contraction of nearly half.
**Revenue model mix.** The company reports two revenue lines only:
Technology revenue is predominantly recurring subscription; professional services is a mix of recurring managed services (TEMS) and project-based, non-recurring engagement revenue. The company explicitly flags fluctuation in "project-based, non-recurring revenue" as a principal risk in every earnings release reviewed.
**Value-chain position.** Health Catalyst sits between the EHR system of record (Epic, Oracle Health) and the health system's executive decision-making layer. It does not own the transactional workflow; it owns the analytic abstraction of it. This is simultaneously its defensibility (EHR vendors historically underinvested in cross-source analytics) and its vulnerability (EHR vendors are now investing heavily, and the 10-K names "the increasing market share of EHR companies in data analytic services, patient engagement and other parts of our Solution" as a specific cause of contract termination risk).
**Customer types and end-markets.** Academic medical centres, integrated delivery networks, community hospitals, large physician practices, Accountable Care Organizations, health information exchanges, health insurers, life-science organisations, healthcare technology vendors (for cybersecurity) and other risk-bearing entities. Named clients in the FY2025 10-K: Allina Health, AlohaCare, Baylor Scott & White Health, Carle Health, Children's Hospital of Orange County, Community Health Network, Contexture, INTEGRIS Health, Lifepoint Health, Mass General Brigham, MultiCare, Queen's Health System, Temple University Health System, UnityPoint Health, UPMC. No client represented more than 10% of total revenue in FY2025, FY2024 or FY2023 (10-K FY2025).
---
